Abstract:Key points Spinal muscular atrophy (SMA) is a health‐ and life‐limiting neuromuscular disorder caused by a deficiency in survival motor neuron (SMN) protein. While historically considered a motor neuron disease, current understanding of SMA emphasizes its systemic nature, which requires addressing affected peripheral tissues such as skeletal muscle in particular. Chronic physical activity is beneficial for SMA patients, however the cellular and molecular mechanisms of exercise biology are largely undefined in SMA. After a single bout of exercise, canonical responses such as skeletal muscle AMPK, p38, and PGC‐1α activation were preserved in SMA‐like Smn 2B/− animals. Furthermore, molecules involved in SMN transcription were also altered following physical activity. Collectively, these changes were coincident with an increase in full‐length SMN transcription and corrective SMN pre‐mRNA splicing. Our study advances understanding of the exercise biology of SMA and highlights the AMPK‐p38‐PGC‐1α axis as a potential regulator of SMN expression in muscle. Chronic physical activity is safe and effective in spinal muscular atrophy (SMA) patients, however the underlying cellular events that drive physiological adaptations are undefined. We examined the effects of a single bout of exercise on molecular mechanisms associated with adaptive remodelling in the skeletal muscle of Smn 2B/− SMA‐like mice. Skeletal muscles were collected from healthy Smn 2B/+ mice and Smn 2B/− littermates at pre‐ [postnatal day (P) 9], early‐ (P13) and late‐symptomatic (P21) stages to characterize SMA disease progression. Muscles were also collected from Smn 2B/− animals exercised to fatigue on a motorized treadmill. Intracellular signalling and gene expression were examined using Western blotting, confocal immunofluorescence microscopy, real‐time quantitative polymerase chain reaction (PCR), and endpoint PCR assays. Basal skeletal muscle AMP‐activated protein kinase (AMPK) and p38 mitogen‐activated protein kinase (p38) expression and activity were not affected by SMA‐like conditions. Canonical exercise responses such as AMPK, p38, and peroxisome proliferator‐activated receptor γ coactivator‐1α (PGC‐1α) activation were observed following a bout of exercise in Smn 2B/− animals. Furthermore, molecules involved in survival motor neuron (SMN) transcription including protein kinase B (AKT) and extracellular signal‐regulated kinases (ERK)/ ETS‐like gene 1 (ELK), were altered following physical activity. Acute exercise was also able to mitigate aberrant proteolytic signalling in the skeletal muscle of Smn 2B/− mice. Collectively, these changes were coincident with an exercise‐evoked increase in full‐length SMN mRNA expression. This study advances our understanding of the exercise biology of SMA and highlights the AMPK‐p38‐PGC‐1α axis as a potential regulator of SMN expression alongside AKT and ERK/ELK signalling. This article is protected by copyright. All rights reserved

Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway

Peripheral Smn Restoration is Essential for Long-Term Rescue of A Severe Spinal Muscular Atrophy Mouse Model

Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes

Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches

Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models.

Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy

A high-throughput genome-wide RNAi screen identifies modifiers of survival motor neuron protein

A spinal muscular atrophy modifier implicates the SMN protein in SNARE complex assembly at neuromuscular synapses

Mechanisms of exercise‐induced survival motor neuron expression in the skeletal muscle of spinal muscular atrophy‐like mice

Targeting SR proteins improves SMN expression in spinal muscular atrophy cells

Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy

Targeted-SMN insufficiency in Skeletal Muscle Stem Cells mediates non-cell autonomous loss of motor neurons at long term

Targeted-Deletion of a Tiny Sequence via Prime Editing to Restore SMN Expression

Improved therapeutic approach for spinal muscular atrophy via ubiquitination‐resistant survival motor neuron variant

The SMN-ribosome interplay: a new opportunity for Spinal Muscular Atrophy therapies

Systems biology investigation of cAMP modulation to increase SMN levels for the treatment of spinal muscular atrophy

Rescue of gene-expression changes in an induced mouse model of spinal muscular atrophy by an antisense oligonucleotide that promotes inclusion of SMN2 exon 7.

Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B

Regulation of Survival Motor Neuron Gene Expression by Calcium Signaling

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy

LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identifies protective pathways in spinal muscular atrophy